NC
NVAX icon

NinePointTwo Capital’s Novavax NVAX Stock Holding History

NinePointTwo Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,477
Closed -$206K – 275
2023
Q3 		$206K Sell
28,477
-6,849
-19% -$54.7K 0.08% 202
2023
Q2 		$262K Sell
35,326
-8,623
-20% -$67.8K 0.1% 101
2023
Q1 		$304K Buy
+43,949
New +$404K 0.11% 43

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NinePointTwo Capital's NVAX Position: Q4 2023 in Review

NinePointTwo Capital sold out of Novavax (NVAX) in Q4 2023, closing a stake of 28,477 shares — an estimated $206K sold.

NinePointTwo Capital first reported a position in NVAX in Q1 2023 and held it in 3 quarters. The position peaked at $304K in Q1 2023. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • NinePointTwo Capital reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • NinePointTwo Capital sold 28,477 Novavax shares in Q4 2023, an estimated $206K.
  • NinePointTwo Capital first reported a position in Novavax in Q1 2023 and held it in 3 quarters.
  • NinePointTwo Capital's Novavax position peaked at $304K in Q1 2023.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.